chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Paraesthesia, Speech disorder
Clinical narrative: Subject, a 33 year old male, with no previous medical conditions, received the 6th dose of Anthrax vaccine (lot # FAV047) on 05/09/00. The patient was taking no concomitant medications at the time of the event. The patient had no previous reactions to the Anthrax vaccines. Approximately two weeks after the 6th Anthrax vaccine, the patient experienced flu-like symptoms with fatigue and myalgia without fever, which completely resolved within 24 hours. In July 2000, the patient reported a 3 week history of intermittent diplopia. In early October 2000, he experienced right-sided paresthesias. In early December 2000, he began having difficulty with finding his words. From 12/21/00 to 02/05/01, he had persistent sensory deficits with deteriorating motor function. As of March 2001, deficits have slightly improved, though the patient remains completely bedridden. The patient was treated with multiple courses of high doses of steroids, IV Immunoglobulin, Interferon beta 1-6, and mitoxantrone. The patient was hospitalized on 12/21/00 and remains hospitalized.
Age: 1.0
Sex: M
Vaccine: DTAP, OPV
Symptoms: Coma, Cough, Dystonia, Erythema, Laboratory test abnormal
Clinical narrative: Case reference number 1998004046-1 is a clinical trial report from study number 208355/117 (Tripedia at 2m and 4M) which is a single-blind study referring to a male aged four months. The patient's past medical history included cough and congestion. The following drugs are also known to have been taken by the patient prior to this event: OmniHib and Orimune on 09/24/97, Tylenol starting 09/24/97, and Dimetapp starting 09/24/97. The patient received his first dose of study vaccine (Tripedia) on 09/24/97, for Diphtheria-Tetanus-Pertussis Prophylaxis. A lump in the right groin was noted the morning of 10/09/97. The infant began treatment with Keflex. Upon recheck, with the physician on 10/10/97 the area was larger, slightly more red and his temperature was up to 101.3 rectal. Ultrasound indicated and inflammatory process. The infant underwent incision and drainage of the right inguinal / femoral lymph node abscess under general anesthesia and spinal block on 10/10/97. The infant was released, and at home his parents gave him a dose of 1-2 ml of Tylenol with Codeine for the pain at approximately 20:30 on 10/10/97. (At 21:30 he was given his 4th dose of Keflex). A few minutes after 21:30 the infant was noted to have his head turning to the right, pupils dilated and he began arching his back with stiffness of all extremities and was unresponsive to parents. The stiffness lasted approximately 1 1/2 hours, with symptoms resolving slowly during the last 30 minutes. He became responsive and started to feed. He was seen in an ER at 22:50. His eyes had become less dilated. The infant did not have a fever. The eventual diagnosis was dystonic reaction to Tylenol with Codeine. The most recent info received reports the event resolved. The investigator reported the dystonic reaction to Tylenol with Codeine not related to the treatment with the study vaccine., but related to Tylenol with Codeine.
Age: 1.0
Sex: M
Vaccine: DTAP, OPV
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Mydriasis, Nasal congestion, Pain
Clinical narrative: Case reference number 1998004046-1 is a clinical trial report from study number 208355/117 (Tripedia at 2m and 4M) which is a single-blind study referring to a male aged four months. The patient's past medical history included cough and congestion. The following drugs are also known to have been taken by the patient prior to this event: OmniHib and Orimune on 09/24/97, Tylenol starting 09/24/97, and Dimetapp starting 09/24/97. The patient received his first dose of study vaccine (Tripedia) on 09/24/97, for Diphtheria-Tetanus-Pertussis Prophylaxis. A lump in the right groin was noted the morning of 10/09/97. The infant began treatment with Keflex. Upon recheck, with the physician on 10/10/97 the area was larger, slightly more red and his temperature was up to 101.3 rectal. Ultrasound indicated and inflammatory process. The infant underwent incision and drainage of the right inguinal / femoral lymph node abscess under general anesthesia and spinal block on 10/10/97. The infant was released, and at home his parents gave him a dose of 1-2 ml of Tylenol with Codeine for the pain at approximately 20:30 on 10/10/97. (At 21:30 he was given his 4th dose of Keflex). A few minutes after 21:30 the infant was noted to have his head turning to the right, pupils dilated and he began arching his back with stiffness of all extremities and was unresponsive to parents. The stiffness lasted approximately 1 1/2 hours, with symptoms resolving slowly during the last 30 minutes. He became responsive and started to feed. He was seen in an ER at 22:50. His eyes had become less dilated. The infant did not have a fever. The eventual diagnosis was dystonic reaction to Tylenol with Codeine. The most recent info received reports the event resolved. The investigator reported the dystonic reaction to Tylenol with Codeine not related to the treatment with the study vaccine., but related to Tylenol with Codeine.
Age: 1.0
Sex: M
Vaccine: DTAP, OPV
Symptoms: Pyrexia, Skin nodule, Torticollis
Clinical narrative: Case reference number 1998004046-1 is a clinical trial report from study number 208355/117 (Tripedia at 2m and 4M) which is a single-blind study referring to a male aged four months. The patient's past medical history included cough and congestion. The following drugs are also known to have been taken by the patient prior to this event: OmniHib and Orimune on 09/24/97, Tylenol starting 09/24/97, and Dimetapp starting 09/24/97. The patient received his first dose of study vaccine (Tripedia) on 09/24/97, for Diphtheria-Tetanus-Pertussis Prophylaxis. A lump in the right groin was noted the morning of 10/09/97. The infant began treatment with Keflex. Upon recheck, with the physician on 10/10/97 the area was larger, slightly more red and his temperature was up to 101.3 rectal. Ultrasound indicated and inflammatory process. The infant underwent incision and drainage of the right inguinal / femoral lymph node abscess under general anesthesia and spinal block on 10/10/97. The infant was released, and at home his parents gave him a dose of 1-2 ml of Tylenol with Codeine for the pain at approximately 20:30 on 10/10/97. (At 21:30 he was given his 4th dose of Keflex). A few minutes after 21:30 the infant was noted to have his head turning to the right, pupils dilated and he began arching his back with stiffness of all extremities and was unresponsive to parents. The stiffness lasted approximately 1 1/2 hours, with symptoms resolving slowly during the last 30 minutes. He became responsive and started to feed. He was seen in an ER at 22:50. His eyes had become less dilated. The infant did not have a fever. The eventual diagnosis was dystonic reaction to Tylenol with Codeine. The most recent info received reports the event resolved. The investigator reported the dystonic reaction to Tylenol with Codeine not related to the treatment with the study vaccine., but related to Tylenol with Codeine.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, OPV
Symptoms: Bacterial infection, Laboratory test abnormal, Meningitis
Clinical narrative: Subject was enrolled in study 208355 / 117 and received her 1st dose of the study vaccine on 09/08/97. Twenty-on days post study medication, the subject was diagnosed with pneumococcal meningitis. She was hospitalized and treated with Ceftriaxone and Penicillin. Fourteen days after onset, the pneumococcal meningitis resolved and the subject was discharged. The investigator reported the pneumococcal meningitis was severe, serious, life-threatening and unrelated to study medication.
Sex: U
Vaccine: DTAP
Symptoms: Bronchiolitis, Cardiac disorder, Coma, Convulsion, Cough
Clinical narrative: Case reference number 1998010461-1 is a clinical trial report from study number 208355/117, which is a single blind study, referring to a 7 month old female. At the time of the event, the subject had Mongolian spots, pale hands, and systolic murmur. Concomitant medications are unspecified. The subject received study vaccine on 10/01/97 and 02/03/98. For three days prior to dose 2, the child had mild upper respiratory illness symptoms (cough, rhinorrhea and fever). The child was afebrile at the time of vaccination. Two days after dose 2, the child developed raised red rash and vomiting x 1. the pediatrician felt the rash was related to a viral illness. the following day the child developed a fever (102.2), but no other symptoms. Four days after dose 2, the child developed 2 minute episodes of arm stiffening, unresponsiveness, and (abnormal) eye movements. Episode was thought to be either a seizure or normal behavior. the child had two more episodes the following day, and was hospitalized with a diagnosis of hypocalcemic seizure, RSV bronchiolitis, Rickets and vitamin D deficiency. She was treated with IV Calcium replacement and vitamin D, Albuterol inhalers, Calciferol, and Titrilac. The most recent info received reports the event resolved. The investigator reported the seizure, bronchiolitis and Rickets not related to treatment with study vaccine, but rather associated with vitamin deficiency RSV infection.
Sex: U
Vaccine: DTAP
Symptoms: Eye disorder, Hypocalcaemia, Musculoskeletal stiffness, Pallor, Pyrexia
Clinical narrative: Case reference number 1998010461-1 is a clinical trial report from study number 208355/117, which is a single blind study, referring to a 7 month old female. At the time of the event, the subject had Mongolian spots, pale hands, and systolic murmur. Concomitant medications are unspecified. The subject received study vaccine on 10/01/97 and 02/03/98. For three days prior to dose 2, the child had mild upper respiratory illness symptoms (cough, rhinorrhea and fever). The child was afebrile at the time of vaccination. Two days after dose 2, the child developed raised red rash and vomiting x 1. the pediatrician felt the rash was related to a viral illness. the following day the child developed a fever (102.2), but no other symptoms. Four days after dose 2, the child developed 2 minute episodes of arm stiffening, unresponsiveness, and (abnormal) eye movements. Episode was thought to be either a seizure or normal behavior. the child had two more episodes the following day, and was hospitalized with a diagnosis of hypocalcemic seizure, RSV bronchiolitis, Rickets and vitamin D deficiency. She was treated with IV Calcium replacement and vitamin D, Albuterol inhalers, Calciferol, and Titrilac. The most recent info received reports the event resolved. The investigator reported the seizure, bronchiolitis and Rickets not related to treatment with study vaccine, but rather associated with vitamin deficiency RSV infection.
Sex: U
Vaccine: DTAP
Symptoms: Rash erythematous, Respiratory syncytial virus infection, Rhinorrhoea, Rickets, Vitamin D deficiency
Clinical narrative: Case reference number 1998010461-1 is a clinical trial report from study number 208355/117, which is a single blind study, referring to a 7 month old female. At the time of the event, the subject had Mongolian spots, pale hands, and systolic murmur. Concomitant medications are unspecified. The subject received study vaccine on 10/01/97 and 02/03/98. For three days prior to dose 2, the child had mild upper respiratory illness symptoms (cough, rhinorrhea and fever). The child was afebrile at the time of vaccination. Two days after dose 2, the child developed raised red rash and vomiting x 1. the pediatrician felt the rash was related to a viral illness. the following day the child developed a fever (102.2), but no other symptoms. Four days after dose 2, the child developed 2 minute episodes of arm stiffening, unresponsiveness, and (abnormal) eye movements. Episode was thought to be either a seizure or normal behavior. the child had two more episodes the following day, and was hospitalized with a diagnosis of hypocalcemic seizure, RSV bronchiolitis, Rickets and vitamin D deficiency. She was treated with IV Calcium replacement and vitamin D, Albuterol inhalers, Calciferol, and Titrilac. The most recent info received reports the event resolved. The investigator reported the seizure, bronchiolitis and Rickets not related to treatment with study vaccine, but rather associated with vitamin deficiency RSV infection.
Sex: U
Vaccine: DTAP
Symptoms: Vomiting
Clinical narrative: Case reference number 1998010461-1 is a clinical trial report from study number 208355/117, which is a single blind study, referring to a 7 month old female. At the time of the event, the subject had Mongolian spots, pale hands, and systolic murmur. Concomitant medications are unspecified. The subject received study vaccine on 10/01/97 and 02/03/98. For three days prior to dose 2, the child had mild upper respiratory illness symptoms (cough, rhinorrhea and fever). The child was afebrile at the time of vaccination. Two days after dose 2, the child developed raised red rash and vomiting x 1. the pediatrician felt the rash was related to a viral illness. the following day the child developed a fever (102.2), but no other symptoms. Four days after dose 2, the child developed 2 minute episodes of arm stiffening, unresponsiveness, and (abnormal) eye movements. Episode was thought to be either a seizure or normal behavior. the child had two more episodes the following day, and was hospitalized with a diagnosis of hypocalcemic seizure, RSV bronchiolitis, Rickets and vitamin D deficiency. She was treated with IV Calcium replacement and vitamin D, Albuterol inhalers, Calciferol, and Titrilac. The most recent info received reports the event resolved. The investigator reported the seizure, bronchiolitis and Rickets not related to treatment with study vaccine, but rather associated with vitamin deficiency RSV infection.
Age: 0.3
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Injection site hypersensitivity, Injection site oedema, Injection site pain, Injection site warmth, Petechiae
Clinical narrative: A nurse practitioner reported that a 4 month old male received injections of Prevnar, Tripedia, IPV, and Comvax on 04/18/01. Within 24 hours of vaccination, the patient developed a generalized petechial rash and an injection site reaction described as "tenderness, redness, warmth, and swelling" at the Prevnar administration site. The reporter also noted that two other injection sites were red and inflamed. On 04/19/2001, the patient was "completely covered with purpura and petechia". He was hospitalized on 04/20/01, for three days with thrombocytopenia (platelet count not provided). the events were treated with immune globulin and the patient is "now doing fine". The follow up info was received on 05/23/2001 that indicated that the pt had  no preexisting illness at the time of vaccination and he received no vaccinations within 4 weeks of 04/18/2001. Follow-up info indicated that the child was seeing another primary care physician and that the reporter in this case had no follow up with the pt since the thrombocytopenia. The physician felt that the thrombocytopenia ha dstarted prior to the vaccination on 04/18/20001. In addition, the pt had no adverse events after the first dose of haemophilus B comjugate vaccine hepatitis b vaccine recombinant, administered at 2 months of age. It was also reported that the child "was expected to make a full recovery." this report was originally reported by a nurse practitioner. Follow-up info indicated that the pt's platelet count was 2000.
Age: 0.3
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Platelet count decreased, Purpura, Thrombocytopenia
Clinical narrative: A nurse practitioner reported that a 4 month old male received injections of Prevnar, Tripedia, IPV, and Comvax on 04/18/01. Within 24 hours of vaccination, the patient developed a generalized petechial rash and an injection site reaction described as "tenderness, redness, warmth, and swelling" at the Prevnar administration site. The reporter also noted that two other injection sites were red and inflamed. On 04/19/2001, the patient was "completely covered with purpura and petechia". He was hospitalized on 04/20/01, for three days with thrombocytopenia (platelet count not provided). the events were treated with immune globulin and the patient is "now doing fine". The follow up info was received on 05/23/2001 that indicated that the pt had  no preexisting illness at the time of vaccination and he received no vaccinations within 4 weeks of 04/18/2001. Follow-up info indicated that the child was seeing another primary care physician and that the reporter in this case had no follow up with the pt since the thrombocytopenia. The physician felt that the thrombocytopenia ha dstarted prior to the vaccination on 04/18/20001. In addition, the pt had no adverse events after the first dose of haemophilus B comjugate vaccine hepatitis b vaccine recombinant, administered at 2 months of age. It was also reported that the child "was expected to make a full recovery." this report was originally reported by a nurse practitioner. Follow-up info indicated that the pt's platelet count was 2000.
Age: 0.3
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: A nurse practitioner reported that a 4 month old male received injections of Prevnar, Tripedia, IPV, and Comvax on 04/18/01. Within 24 hours of vaccination, the patient developed a generalized petechial rash and an injection site reaction described as "tenderness, redness, warmth, and swelling" at the Prevnar administration site. The reporter also noted that two other injection sites were red and inflamed. On 04/19/2001, the patient was "completely covered with purpura and petechia". He was hospitalized on 04/20/01, for three days with thrombocytopenia (platelet count not provided). the events were treated with immune globulin and the patient is "now doing fine". The follow up info was received on 05/23/2001 that indicated that the pt had  no preexisting illness at the time of vaccination and he received no vaccinations within 4 weeks of 04/18/2001. Follow-up info indicated that the child was seeing another primary care physician and that the reporter in this case had no follow up with the pt since the thrombocytopenia. The physician felt that the thrombocytopenia ha dstarted prior to the vaccination on 04/18/20001. In addition, the pt had no adverse events after the first dose of haemophilus B comjugate vaccine hepatitis b vaccine recombinant, administered at 2 months of age. It was also reported that the child "was expected to make a full recovery." this report was originally reported by a nurse practitioner. Follow-up info indicated that the pt's platelet count was 2000.
Age: 0.3
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Petechiae, Purpura, Thrombocytopenia
Clinical narrative: A nurse practitioner reported that a 4 month old male received injections of Prevnar, Tripedia, IPV, and Comvax on 04/18/01. Within 24 hours of vaccination, the patient developed a generalized petechial rash and an injection site reaction described as "tenderness, redness, warmth, and swelling" at the Prevnar administration site. The reporter also noted that two other injection sites were red and inflamed. On 04/19/2001, the patient was "completely covered with purpura and petechia". He was hospitalized on 04/20/01, for three days with thrombocytopenia (platelet count not provided). the events were treated with immune globulin and the patient is "now doing fine". The follow up info was received on 05/23/2001 that indicated that the pt had  no preexisting illness at the time of vaccination and he received no vaccinations within 4 weeks of 04/18/2001. Follow-up info indicated that the child was seeing another primary care physician and that the reporter in this case had no follow up with the pt since the thrombocytopenia. The physician felt that the thrombocytopenia ha dstarted prior to the vaccination on 04/18/20001. In addition, the pt had no adverse events after the first dose of haemophilus B comjugate vaccine hepatitis b vaccine recombinant, administered at 2 months of age. It was also reported that the child "was expected to make a full recovery." this report was originally reported by a nurse practitioner. Follow-up info indicated that the pt's platelet count was 2000.
Age: 5.0
Sex: F
Vaccine: DTAP, HBHEPB, IPV, MMR
Symptoms: Convulsion, Cough, Pneumonia, Pyrexia
Clinical narrative: This child received her immunizations at 11 AM on 02/14/01. By 1:30 PM, she had a fever of 101. It peaked at 103. The next morning she had a seizure. The mother took her to their family physician. She was admitted to the hospital and diagnosed with pneumonia. She was treated with IV antibiotics and discharged on 02/18/01. She had been seen on 02/12/01 at the ER for a dry cough. Discharged. Chest x-ray had been negative. The child is doing well at the present.
Age: 0.6
Sex: M
Vaccine: DTAP, HBHEPB, IPV
Symptoms: Hypersensitivity, Pyrexia, Viral infection
Clinical narrative: Immunizations administered approximately 2:30 PM on 04/23/01. 3 hours later, the infant began running a fever of 103 - 104. Used both Tylenol and Motrin, and fever stayed elevated. The infant was seen by a doctor and admitted to the hospital for 24 hours after the spinal tap was normal, the doctor felt it was probably a virus. Fever Wednesday 04/24/01 101 - 102 but the infant was acting normal. Diagnosed with allergic reaction to pertussis vaccine.
Age: 1.25
Sex: M
Vaccine: HEP, IPV, MMR, PNC, VARCEL
Symptoms: Vomiting
Clinical narrative: One hour after injection this infant started vomiting 8 times in 1 hour, stopped after approximately 3 hours, no fever.
Age: 3.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Erythema, Oedema, Pruritus
Clinical narrative: Redness and swelling of the left arm 3 x 4 circumference, and itching.
Age: 0.2
Sex: F
Vaccine: DTAP, IPV, MEA, PNC
Symptoms: Convulsion, Sleep disorder
Clinical narrative: On the day of immunizations the infant had no problem. However, the next day the infant had 13 hours with no sleep followed by 10 minutes of sleep, then a seizure lasting less than 60 seconds. The infant was taken to the ER, a chest x-ray was done. Visited Ped. Upper GI done on 05/07/01 with normal results.
Age: 2.0
Sex: F
Vaccine: PNC
Symptoms: Pyrexia
Clinical narrative: This patient had a temp of 101, 12 hours after injection of Prevnar at 2 years old.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Coma, Hypotension, Pallor, Petechiae
Clinical narrative: The pt experienced pallor, hypotension, unresponsiveness, petechiae to the lower extremities.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR, PNC
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Mother reported redness and swelling to bilateral arms, deltoid areas (8 hours after immunizations). The child was afebrile, skin was soft to touch, no drainage from sites, positive measurement taken, (+) gm check, (+) mvt of cxt. Recheck in 2 days.
Age: 1.25
Sex: M
Vaccine: DTAP, HEP, PNC
Symptoms: Pyrexia, Urticaria
Clinical narrative: following vaccine the pt developed hives on torso and fever of 101.
Age: 3.0
Sex: M
Vaccine: PNC
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Injection site pain, Skin discolouration
Clinical narrative: The pt experienced a localized reaction that 12 cm area of redness, swelling, induration, tenderness and dark skin color.
Age: 1.0
Sex: F
Vaccine: MMR, PNC
Symptoms: Rash maculo-papular
Clinical narrative: On 4/26/01 the pt experienced  a maculo-papular erythema eruption over the extremities.
Age: 0.75
Sex: F
Vaccine: PNC
Symptoms: Agitation, Irritability, Pyrexia, Sleep disorder
Clinical narrative: Information from mom. On 01/25/01, infant was fussy that evening, temp 99, Tylenol every 4 hours. On 01/26/01, Temp was 101 - 102 during the day, Tylenol every 4 hours, temp was 103 approximately 7 PM. On 01/27/01, 5 AM, taken to the hospital, temp 105.5 "rectal", fussy. crying, couldn't sleep; ER gave Tylenol.
Age: 2.0
Sex: F
Vaccine: HEPA, PNC
Symptoms: Unevaluable event
Clinical narrative: No data provided.
Age: 1.5
Sex: F
Vaccine: DTAP, HIBV, PNC, VARCEL
Symptoms: Dermatitis bullous, Injection site infection, Injection site oedema, Injection site vesicles
Clinical narrative: Mom states one day post vax, the child's arm swelled up and was sore. She applied cool compresses and gave Tylenol. This all went away the next day. On 4/13/01, the other arm had a blister almost like chicken pox. On 4/14/01, the pt's grandmother thought it looked infected but to wait until the pt saw the doctor. On 4/16/01 the pt saw a doctor and was placed on antibiotics. On 4/18/01 the pt went to the ER and was told by the ER MD it was a sterile pox, and no further treatment was needed.
Age: 46.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Arthropathy, Laboratory test abnormal, Muscular weakness, Myalgia
Clinical narrative: The pt experienced multiple joint and muscle pain of severe intensity that has been somewhat migratory, often bilateral accompanied by joint laxity and muscle weakness resulting in severe compromise of all ADL activities and functional mobility. Treated by rheumatologist  with dilofenal and sylfasalazine
Age: 46.0
Sex: F
Vaccine: LYME
Symptoms: Red blood cell sedimentation rate increased
Clinical narrative: The pt experienced multiple joint and muscle pain of severe intensity that has been somewhat migratory, often bilateral accompanied by joint laxity and muscle weakness resulting in severe compromise of all ADL activities and functional mobility. Treated by rheumatologist  with dilofenal and sylfasalazine
Age: 49.0
Sex: M
Vaccine: LYME
Symptoms: Headache, Joint stiffness, Joint swelling, Muscular weakness
Clinical narrative: The pt experienced stiffness, swelling joints of legs, headaches, and weakness in legs.
Age: 52.0
Sex: F
Vaccine: LYME
Symptoms: Arthritis
Clinical narrative: A couple of months following dose 3 of Lymerix, the pt experienced unspecified symptoms. She subsequently diagnosed herself with traveling arthritis. The pt stated that her primary care physician has not diagnosed her with "traveling arthritis. As of 5/2/01, the outcome of the event was ongoing.
Age: 1.4
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Agitation, Cellulitis, Injection site erythema, Injection site oedema, Injection site reaction
Clinical narrative: The pt spiked a temp of 102.9, broke out in whelps to legs, arms and neck. The pt developed inconsolable crying and whining, redness and swelling to the injection site. Given Tylenol, and Benadryl. The following day the pt had developed cellulitis , swelling, warm to the touch and redness to the injection site. Treated with Keflex.
Age: 1.4
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Injection site warmth, Pyrexia, Urticaria
Clinical narrative: The pt spiked a temp of 102.9, broke out in whelps to legs, arms and neck. The pt developed inconsolable crying and whining, redness and swelling to the injection site. Given Tylenol, and Benadryl. The following day the pt had developed cellulitis , swelling, warm to the touch and redness to the injection site. Treated with Keflex.
Age: 1.25
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Injection site is hot,  red, swollen to a 3" area at injection site.
Age: 19.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Feeling cold, Feeling hot
Clinical narrative: A few hours post vax the pt got hot and cold and then became light headed. The symptoms have stopped. The site of injection is soft, no redness. Denies fever.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Erythema multiforme
Clinical narrative: The pt developed erythema multiforme, treated with Benadryl and 5 day course of prednisolone.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site haemorrhage, Injection site rash, Injection site urticaria, Injection site vesicles
Clinical narrative: The pt experienced an injection site welt the size of a quarter and blisters appeared around injection site within a few days. Rash resolved and then bruise appeared.
Age: 1.5
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site urticaria, Pyrexia, Vaccine positive rechallenge
Clinical narrative: 20 minutes post vax, the pt had a local reaction at the DTAP site. 2 hours later hives appeared on arms and neck. The pt also experienced a low grade fever. Treated with Benadryl and Tylenol.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Oedema peripheral
Clinical narrative: 2 days later, a mother called and stated her daughters arm (left arm) was swollen considerably down to her fingers. The mother was encouraged to put ice on the arm and take her to the family doctor. The doctor saw the child and confirmed reaction and placed her on Clariton.
Age: 2.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema, Pyrexia
Clinical narrative: This mother states the child had a localized reaction, noted 24 hours after vaccination. The site had erythema and swelling as stated by the mother. The client was seen on 04/27 erythema resolved and above knee notably edematous compared to the right leg. Low grade fever of 99 degrees, and less after the shot. Tylenol was given as ordered.
Age: 1.4
Sex: F
Vaccine: DTAP
Symptoms: Dyskinesia, Pyrexia
Clinical narrative: This child received a 4th DTaP approximately at 9 AM on 04/17/2001. Gave her Motrin requirement because she tended to run a fever after DTaP. Did not continue Motrin on Wednesday. AM 04/18/01. The baby sitter reported an episode of whole body jerking on Wednesday in the AM. They lasted about 2 minutes. The grandmother observed same thing about 5 PM on 04/18/01. Temp was 102.5 at that time. Not checked again after that. Nothing else noted since.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: The pt developed a full blown case of chicken pox that was severe. The pt was sent to an eye doctor because of the pox around the eyes.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: This child had a 10 x 10 cm erythematous area with slight induration at the left thigh.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Feeling hot, Injection site erythema, Injection site oedema
Clinical narrative: This child had a 2" reddened, warm area on the left upper arm, with slight swelling on the left lower arm. Advised Benadryl and cool compresses.
Age: 52.0
Sex: M
Vaccine: PPV, TD
Symptoms: Erythema, Injection site pain, Myalgia, Pyrexia
Clinical narrative: This patient had a fever, muscle aches, erythema, and pain to the site. Tylenol and Benadryl.
Age: 0.75
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Injection site pain, Rash erythematous
Clinical narrative: The pt experienced a red, raised bump slightly larger than a quarter on the left leg with leg pain, that is getting worse in past 24 hours on day 7 post vax. Instructed to be evaluated by pediatrician. Pediatrician described a normal mild reaction. No treatment required.
Age: 26.0
Sex: F
Vaccine: HEPA
Symptoms: Dyspnoea, Urticaria
Clinical narrative: The pt developed hives and shortness of breath. Went to urgent care for treatment.
Age: 2.0
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Drug ineffective, Infection, Pruritus, Pyrexia
Clinical narrative: On 5/3/01 the pt was covered with chicken pox, treated symptoms with Tylenol for fever and Benadryl for itch.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: The pt developed chicken box on 5/2/01.
Age: 47.0
Sex: F
Vaccine: HEP
Symptoms: Chills, Condition aggravated, Injection site erythema, Paraesthesia
Clinical narrative: The pt experienced erythema, arm tingling, numbness, right leg numbness and chills. The pt also experienced uncontrolled arrhythmia.
Age: 15.0
Sex: F
Vaccine: HEP
Symptoms: Asthenia, Injection site pain, Neuropathy
Clinical narrative: The pt experienced pain and weakness at the injection site, possible neuropathy.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site pain, Injection site warmth, Rash erythematous
Clinical narrative: The pt experienced severe hot, raised red and white rash with accompanied pain noticed upon awakening the following morning. Motrin was given 2 hours later at the doctors office.
Age: 39.0
Sex: F
Vaccine: TD
Symptoms: Chest pain, Dyspnoea, Hyperhidrosis, Hypoaesthesia, Myalgia
Clinical narrative: 2 days, post vax, I woke up at approx. 00:30 AM, with chest pain,  shortness of breath, sweating and nausea. I was taken to ER by EMS. Ruled out MI but admitted for observation. Released the next day. Had numbness and tingling which began on the left side of my face, left arm, left side and left leg. Numbness and tingling varies in severity from day to day. Chest pain and severe numbness again on 5/2/01 with pain in the muscle where numbness present.
Age: 39.0
Sex: F
Vaccine: TD
Symptoms: Nausea
Clinical narrative: 2 days, post vax, I woke up at approx. 00:30 AM, with chest pain,  shortness of breath, sweating and nausea. I was taken to ER by EMS. Ruled out MI but admitted for observation. Released the next day. Had numbness and tingling which began on the left side of my face, left arm, left side and left leg. Numbness and tingling varies in severity from day to day. Chest pain and severe numbness again on 5/2/01 with pain in the muscle where numbness present.
Age: 1.6
Sex: F
Vaccine: HBHEPB, MMR, PNC, VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: The pt experienced 100 spots (+) varicella. Exposed to sibling with varicella 3 days ago.
Age: 0.4
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Agitation, Hypotonia, Pyrexia
Clinical narrative: The pt experienced a fever to 103 and inconsolable fussiness the night of the vaccine. 2 1/2 days post vax, the pt had an episode of hypotonia.
Age: 1.25
Sex: M
Vaccine: HEP, HIBV, MMR, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: The pt experienced a fever of 102 and a seizure.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site reaction, Injection site warmth
Clinical narrative: The pt experienced redness and swelling at the injection site. The pt also experienced a raised, red, warm area which was non-tender on the right upper arm. Diagnosed as probable local reaction to immunization, possible cellulitis. Given Augmentin for 10 days.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Rash erythematous
Clinical narrative: The pt experienced redness and swelling at the injection site. The pt also experienced a raised, red, warm area which was non-tender on the right upper arm. Diagnosed as probable local reaction to immunization, possible cellulitis. Given Augmentin for 10 days.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: The pt experiences left arm redness and swelling. Seen in the ER on 4/15/01. The left upper arm had a circular, reddened area surrounding vax site. Minimally tender to the touch, slightly warm, slightly indurated suggesting a local reaction to vax. The pt was released home in good condition. No meds given until 4/16/01. Augmentin was given per moms request. Arm was discolored for 2 weeks.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Skin discolouration
Clinical narrative: The pt experiences left arm redness and swelling. Seen in the ER on 4/15/01. The left upper arm had a circular, reddened area surrounding vax site. Minimally tender to the touch, slightly warm, slightly indurated suggesting a local reaction to vax. The pt was released home in good condition. No meds given until 4/16/01. Augmentin was given per moms request. Arm was discolored for 2 weeks.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: The pt was seen in the ER on 3/25/01 because of redness and swelling, warmth and erythema involving the lateral aspect of the arm near the shoulder. The erythema stretches about 15cm from the shoulder to the elbow. Treated with water soaks, elevate arm and proscribed Keflex. Diagnosed with Cellulitis of the arm. Antibiotics changed to Augmentin.
Age: 1.25
Sex: M
Vaccine: DTAP
Symptoms: Hypersensitivity, Injection site erythema, Injection site infection, Injection site mass, Injection site oedema
Clinical narrative: The pt experienced a red knot on the thigh, felt like a golf ball. On 4/21/01 the pt was seen in the ER for increased swelling and fever of 100.2. Exam revealed a 12 x 10 cm erythematous area on the anterior aspect of the right thigh. R/O infection at vax site versus delayed allergic reaction. Given IV Rocephin. Given Benadryl.
Age: 1.25
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia
Clinical narrative: The pt experienced a red knot on the thigh, felt like a golf ball. On 4/21/01 the pt was seen in the ER for increased swelling and fever of 100.2. Exam revealed a 12 x 10 cm erythematous area on the anterior aspect of the right thigh. R/O infection at vax site versus delayed allergic reaction. Given IV Rocephin. Given Benadryl.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Urticaria
Clinical narrative: Within 1 hour the pt broke out in hives. No respiratory problems. Treated with prednisone and antihistamines. discharged home.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Pruritus
Clinical narrative: The pt experienced a 2.5 x 2 cm area of induration, swelling, variable erythema, slightly itchy. Treated with Benadryl and watching for symptoms of cellulitis.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema
Clinical narrative: Left arm injection site is pink.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: The pt experienced a varicella infection 13 months post vax.
Age: 27.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Chest pain, Dysphonia, Face oedema, Injection site oedema, Injection site swelling
Clinical narrative: Information has been received from a health professional concerning a 27 year old female who on 3/21/01 at 16:15 was vaccinated in the left arm with MMRII. The pt had been vaccinated with measles-rubella on 1/30/96 and with Mumps vaccine on 10/31/97. At 16:50, the pt returned to the office with swelling in the face, hoarseness of the voice, chest pain, periorbital edema of the left eye and injection site raised, swollen and warm to touch. The pt also experienced chills and shortness of breath. The pt was in moderate distress. She was taken to ER and administered Benadryl, epinephrine, oxygen, Solu-Medrol and potassium chloride. She was admitted for observation. There was moderate edema on the left side of the face. It was noted that the tympanic membrane was perforated bilaterally. The throat was clear. The neck was supple and without nodes, masses, 'TM' or 'JVD'. Lungs were clear to auscultation. The abdomen was soft, non-tender and without masses or hepatosplenomegally. The skin was 'WTD' without lesions. At 17:30, exam revealed temperature was 97.1F, pulse rate 70, respiratory rate 20, BP 121/85 and oxygen saturation 98. The pt was dx'd with an anaphylactoid reaction and severe hypokalemia. By 3/22/01, her status was improved and she was discharged from the hospital. No further information is available. The pt recovered on 03/22/2000.
Age: 27.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Injection site warmth
Clinical narrative: Information has been received from a health professional concerning a 27 year old female who on 3/21/01 at 16:15 was vaccinated in the left arm with MMRII. The pt had been vaccinated with measles-rubella on 1/30/96 and with Mumps vaccine on 10/31/97. At 16:50, the pt returned to the office with swelling in the face, hoarseness of the voice, chest pain, periorbital edema of the left eye and injection site raised, swollen and warm to touch. The pt also experienced chills and shortness of breath. The pt was in moderate distress. She was taken to ER and administered Benadryl, epinephrine, oxygen, Solu-Medrol and potassium chloride. She was admitted for observation. There was moderate edema on the left side of the face. It was noted that the tympanic membrane was perforated bilaterally. The throat was clear. The neck was supple and without nodes, masses, 'TM' or 'JVD'. Lungs were clear to auscultation. The abdomen was soft, non-tender and without masses or hepatosplenomegally. The skin was 'WTD' without lesions. At 17:30, exam revealed temperature was 97.1F, pulse rate 70, respiratory rate 20, BP 121/85 and oxygen saturation 98. The pt was dx'd with an anaphylactoid reaction and severe hypokalemia. By 3/22/01, her status was improved and she was discharged from the hospital. No further information is available. The pt recovered on 03/22/2000.
Age: 27.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Anaphylactoid reaction, Blood glucose increased, Blood pressure increased, Chest pain, Chills
Clinical narrative: Information has been received from a health professional concerning a 27 year old female who on 3/21/01 at 16:15 was vaccinated in the left arm with MMRII. The pt had been vaccinated with measles-rubella on 1/30/96 and with Mumps vaccine on 10/31/97. At 16:50, the pt returned to the office with swelling in the face, hoarseness of the voice, chest pain, periorbital edema of the left eye and injection site raised, swollen and warm to touch. The pt also experienced chills and shortness of breath. The pt was in moderate distress. She was taken to ER and administered Benadryl, epinephrine, oxygen, Solu-Medrol and potassium chloride. She was admitted for observation. There was moderate edema on the left side of the face. It was noted that the tympanic membrane was perforated bilaterally. The throat was clear. The neck was supple and without nodes, masses, 'TM' or 'JVD'. Lungs were clear to auscultation. The abdomen was soft, non-tender and without masses or hepatosplenomegally. The skin was 'WTD' without lesions. At 17:30, exam revealed temperature was 97.1F, pulse rate 70, respiratory rate 20, BP 121/85 and oxygen saturation 98. The pt was dx'd with an anaphylactoid reaction and severe hypokalemia. By 3/22/01, her status was improved and she was discharged from the hospital. No further information is available. The pt recovered on 03/22/2000.
Age: 27.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Dysphonia, Dyspnoea, Face oedema, Haematuria, Hypokalaemia
Clinical narrative: Information has been received from a health professional concerning a 27 year old female who on 3/21/01 at 16:15 was vaccinated in the left arm with MMRII. The pt had been vaccinated with measles-rubella on 1/30/96 and with Mumps vaccine on 10/31/97. At 16:50, the pt returned to the office with swelling in the face, hoarseness of the voice, chest pain, periorbital edema of the left eye and injection site raised, swollen and warm to touch. The pt also experienced chills and shortness of breath. The pt was in moderate distress. She was taken to ER and administered Benadryl, epinephrine, oxygen, Solu-Medrol and potassium chloride. She was admitted for observation. There was moderate edema on the left side of the face. It was noted that the tympanic membrane was perforated bilaterally. The throat was clear. The neck was supple and without nodes, masses, 'TM' or 'JVD'. Lungs were clear to auscultation. The abdomen was soft, non-tender and without masses or hepatosplenomegally. The skin was 'WTD' without lesions. At 17:30, exam revealed temperature was 97.1F, pulse rate 70, respiratory rate 20, BP 121/85 and oxygen saturation 98. The pt was dx'd with an anaphylactoid reaction and severe hypokalemia. By 3/22/01, her status was improved and she was discharged from the hospital. No further information is available. The pt recovered on 03/22/2000.
Age: 27.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Injection site swelling, Injection site warmth, Tympanic membrane perforation
Clinical narrative: Information has been received from a health professional concerning a 27 year old female who on 3/21/01 at 16:15 was vaccinated in the left arm with MMRII. The pt had been vaccinated with measles-rubella on 1/30/96 and with Mumps vaccine on 10/31/97. At 16:50, the pt returned to the office with swelling in the face, hoarseness of the voice, chest pain, periorbital edema of the left eye and injection site raised, swollen and warm to touch. The pt also experienced chills and shortness of breath. The pt was in moderate distress. She was taken to ER and administered Benadryl, epinephrine, oxygen, Solu-Medrol and potassium chloride. She was admitted for observation. There was moderate edema on the left side of the face. It was noted that the tympanic membrane was perforated bilaterally. The throat was clear. The neck was supple and without nodes, masses, 'TM' or 'JVD'. Lungs were clear to auscultation. The abdomen was soft, non-tender and without masses or hepatosplenomegally. The skin was 'WTD' without lesions. At 17:30, exam revealed temperature was 97.1F, pulse rate 70, respiratory rate 20, BP 121/85 and oxygen saturation 98. The pt was dx'd with an anaphylactoid reaction and severe hypokalemia. By 3/22/01, her status was improved and she was discharged from the hospital. No further information is available. The pt recovered on 03/22/2000.
Age: 27.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Anaphylactoid reaction, Blood pressure increased, Chest pain, Dysphonia, Hypokalaemia
Clinical narrative: Information has been received from a health professional concerning a 27 year old female who on 3/21/01 at 16:15 was vaccinated in the left arm with MMRII. The pt had been vaccinated with measles-rubella on 1/30/96 and with Mumps vaccine on 10/31/97. At 16:50, the pt returned to the office with swelling in the face, hoarseness of the voice, chest pain, periorbital edema of the left eye and injection site raised, swollen and warm to touch. The pt also experienced chills and shortness of breath. The pt was in moderate distress. She was taken to ER and administered Benadryl, epinephrine, oxygen, Solu-Medrol and potassium chloride. She was admitted for observation. There was moderate edema on the left side of the face. It was noted that the tympanic membrane was perforated bilaterally. The throat was clear. The neck was supple and without nodes, masses, 'TM' or 'JVD'. Lungs were clear to auscultation. The abdomen was soft, non-tender and without masses or hepatosplenomegally. The skin was 'WTD' without lesions. At 17:30, exam revealed temperature was 97.1F, pulse rate 70, respiratory rate 20, BP 121/85 and oxygen saturation 98. The pt was dx'd with an anaphylactoid reaction and severe hypokalemia. By 3/22/01, her status was improved and she was discharged from the hospital. No further information is available. The pt recovered on 03/22/2000.
Age: 27.0
Sex: F
Vaccine: MMR, MMR, MMR
Symptoms: Swelling face
Clinical narrative: Information has been received from a health professional concerning a 27 year old female who on 3/21/01 at 16:15 was vaccinated in the left arm with MMRII. The pt had been vaccinated with measles-rubella on 1/30/96 and with Mumps vaccine on 10/31/97. At 16:50, the pt returned to the office with swelling in the face, hoarseness of the voice, chest pain, periorbital edema of the left eye and injection site raised, swollen and warm to touch. The pt also experienced chills and shortness of breath. The pt was in moderate distress. She was taken to ER and administered Benadryl, epinephrine, oxygen, Solu-Medrol and potassium chloride. She was admitted for observation. There was moderate edema on the left side of the face. It was noted that the tympanic membrane was perforated bilaterally. The throat was clear. The neck was supple and without nodes, masses, 'TM' or 'JVD'. Lungs were clear to auscultation. The abdomen was soft, non-tender and without masses or hepatosplenomegally. The skin was 'WTD' without lesions. At 17:30, exam revealed temperature was 97.1F, pulse rate 70, respiratory rate 20, BP 121/85 and oxygen saturation 98. The pt was dx'd with an anaphylactoid reaction and severe hypokalemia. By 3/22/01, her status was improved and she was discharged from the hospital. No further information is available. The pt recovered on 03/22/2000.